| |
| J Pouch Reversal |
| J Pouch Reversal J pouch reversal is takedown and removal of the J pouch with either BCIR continent ileostomy or conventional ileostomy. |
| |
|
| |
| |
| |
(source: Southern Medical Journal).
More Information (source: Southern Medical Journal).
|
12/31/1969 03:59 PM
|
|
Port Site Metastasis Remote from the Time of Initial Laparoscopy.: GYN/OB-2
|
and descending end colostomy with Hartmann's pouch formation. She received carboplatin and In June 2002, the patient underwent a colostomy reversal with no evidence of disease at surgery. In
|
|
12/31/1969 03:59 PM
|
|
Anemia Following Roux-en-Y Surgery for Morbid Obesity: A Review
|
Morbid obesity is a significant problem in the Western world. Recently, there has been an increase in the number of patients undergoing surgical weight loss procedures. Currently, the most widely performed procedure is the Roux-en-Y gastric bypass operation which combines restriction of food intake with malabsorption of calories and various nutrients, resulting in weight loss and nutritional deficiencies, respectively. Various types of anemia may complicate Roux-en-Y and commonly include deficiencies of iron, folate, and vitamin B12. Iron deficiency is particularly common and may result from many mechanisms including poor intake, malabsorption, and mucosal bleeding from marginal ulceration. However, less appreciated etiologies of nutritional anemia include deficiencies of B-complex vitamins, ascorbic acid, and copper. Replacement of the missing or decreased constituent usually reverses the anemia. Since physicians of various medical and surgical specialties are often involved with the postoperative care of bariatric patients, a review of anemia in this patient population is warranted.
(C) 2008 Southern Medical Association
|
|
12/31/1969 03:59 PM
|
|
Pediatric Obesity: Impact and Surgical Management
|
The incidence of children in the United States who are overweight or obese is increasing at an alarming rate, and many obesity-related complications are now being described in children. There appears to be no current pharmacologic treatment or surgical procedure that is both safe and effective for millions of obese children. Bariatric surgery may be useful, however, in carefully selected obese children with associated serious comorbidities unresponsive to medical or dietary interventions. The complications of pediatric obesity are discussed, as well as current medical and surgical management of this disorder.
(C) 2006 Southern Medical Association
|
|
12/31/1969 03:59 PM
|
|
Metabolic, Renal, and Nutritional Consequences of Bariatric Surgery: Implications for the Clinician
|
Management of obesity-associated comorbidities costs about $60 billion/year, about 5% of total US healthcare expenditure. Bariatric surgery is the only proven effective weight loss therapy for severely obese patients with a BMI >=35 kg/m2. Bariatric surgery produces long-term weight loss, improves quality of life, and reduces the number of sick days and medication costs. Surgery has a profound effect on the metabolic milieu and nutritional status from the first few days after surgery, even before significant weight loss has been achieved. Metabolic effects of bariatric surgery reduce obesity-related comorbidities like type 2 diabetes, hypertension, metabolic syndrome, and cardiovascular disease risk. Improvement in renal function is seen, but adverse effects like oxalate nephropathy can lead to chronic kidney disease or end-stage renal disease (CKD/ESRD). Surgery can also lead to micronutrient deficiencies, making dietary supplementation necessary. Reduction in insulin resistance and hypertension after surgery makes medication adjustment imperative. Improvement in comorbidities and nutritional deficiencies after bariatric surgery has important clinical implications.
(C) 2010 Southern Medical Association
|
|
|
|
| |
|
|
|
